Angiocentric lymphomas (lymphomatous vasculitis)

Seminars in Diagnostic Pathology

Volumn 18, Issue 1, 2001, Pages 67-77

  Natkunam, Y ^a   Warnke, R A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiocentric; Extranodal; Natural killer; NK T cell lymphoma; Peripheral T cell lymphoma; Vasculitis

Indexed keywords

ANGIOCENTRIC LYMPHOMA; B CELL LYMPHOMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA; VASCULITIS;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; NOSE NEOPLASMS; VASCULAR NEOPLASMS;

EID: 0035122972     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group
2. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues
3. Perivascular Ki-l + lesions
4. A small-cell-predominant variant of primary Ki-l (CD30)+ T-cell lymphoma
5. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
6. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes
7. Subcutaneous tissue involvement by T-cell lymphoma. A report of 2 cases
8. Subcutaneous panniculitis-like T-cell lymphoma: Clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes
9. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome
10. Nonhepatosplenic gammadelta T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization
11. Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytes
12. Angiocentric immunoproliferative lesions of the lymph node
13. Lymphomatoid granulomatosis: Pathogenesis, pathology and clinical implications
14. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site
15. Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis
16. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection
17. Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma
18. Reassessment of malignant angioendotheliomatosis: Evidence in favor of its reclassification as intravascular lymphomatosis
19. Neoplastic angioendotheliomatosis: Immunopathologic and morphologic evidence for intravascular malignant lymphomatosis
20. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma
21. Peripheral T-cell and NK-cell neoplasms: An integrated approach to diagnosis
22. Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Definitions, differential diagnosis and epidemiology
23. Extranodal peripheral T-cell and NK-cell neoplasms
24. Tumors of the Lymph Nodes and Spleen
25. Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
26. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
27. Posttransplant T-cell lymphoproliferative disorders - An aggressive, late complication of solid-organ transplantation
28. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
29. Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
30. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
31. The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms
32. CD56 (NKHl)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity
33. The expression of TIA-I+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): Correlation with morphology, immunophenotype, ultrastructure, and clinical features
34. Expression of Epstein-Bart virus encoded latent genes in nasal T cell lymphomas
35. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: Clinicopathologic, immunohistochemical and molecular analyses of seven cases
36. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
37. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection
38. Extranodal head and neck lymphomas in Guatemala: High frequency of Epstein-Barr virus-associated sinonasal lymphomas
39. Histological and immunophenotypic profile of nasal NK/T cell lymphoma from Peru: High prevalence of p53 overexpression
40. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement
41. Clinicopathological features of CD56+ nasal-type T/natural killer cell lymphomas with lobular panniculitis
42. Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides
43. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors
44. Neural cell adhesion molecule distribution in soft tissue tumors
45. HLA-DR-.CD33+. CD56+. CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
46. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity
47. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
48. Discordant CD3 expression in lymphomas when studied On frozen and paraffin sections
49. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: The neoplastic cells are often CD3 epsilon+
50. Cutaneous monomorphous CD4- and CD56- positive large-cell lymphoma
51. CD4+ CD56+ cutaneous neoplasms: A distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC)
52. CD2-. CD4+. CD56+ agranular natural killer cell lymphoma of the skin
53. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract
54. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
55. Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study
56. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient
57. Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitors
58. Acute lymphoblastic leukemia/lymphoblastic lymphoma of natural killer (NK) lineage: Quest for another NK-lineage neoplasm
59. A child case of CD34+. CD33-. HLA-DR-. CD7+. CD56+ stem cell leukemia with thymic involvement
60. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
61. Recognition of unusual presentation of natural killer cell leukemia
62. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)
63. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance
64. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
65. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation